NCT02335112

Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms

Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms: Phase I and Phase II Clinical Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 15 (actual)
• Sponsor: Fuda Cancer Hospital, Guangzhou · Academic / Other
• Sex: All
• Age: —
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate the safety and efficacy of irreversible electroporation (IRE) for unresectable Head and Neck Neoplasms.

Detailed description

By enrolling patients with unresectable Head and Neck Neoplasms adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of percutaneous IRE for unresectable Head and Neck Neoplasms.

Conditions

• Head and Neck Neoplasms

Interventions

Type	Name	Description
PROCEDURE	Irreversible electroporation (IRE)	Irreversible Electroportion For Unresectable Head and Neck Neoplasms guide with ultrasound or/and CT.
DEVICE	NanoKnife

Timeline

• Start date: 2015-01-01
• Primary completion: 2020-12-01
• Completion: 2021-01-01
• First posted: 2015-01-09
• Last updated: 2021-09-05

Locations

1 site across 1 country: China